Downregulation of HIF-lα inhibits the proliferation and invasion of non-small cell lung cancer NCI-H157 cells

Oncology Letters

Volumn 11, Issue 3, 2016, Pages 1738-1744

  Qian, Jialin ^a   Bai, Hao ^a   Gao, Zhiqiang ^a   Dong, Yu ^a   Pei, Jun ^a   Ma, Meili ^a   Han, Baohui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Downregulation; Inhibit; Non small cell lung cancer

Indexed keywords

B CELL LYMPHOMA 2; CASPASE 3; CASPASE 9; CISPLATIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA SMALL INTERFERING RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL COUNTING; CELL CULTURE; CELL INVASION; CELL INVASION ASSAY; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NON SMALL CELL LUNG CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TRANSWELL ASSAY; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84958092969     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4150     Document Type: Article

References (45)

1. Fenton-Ambrose L and Kazerooni EA: Preventative care: Lung-cancer screens now worth the cost. Nature 514: 35, 2014.
2. Ellis P: Minimally invasive thoracic surgery for early stage non-small cell lung cancer. BMJ 349: g5849, 2014.
3. Lococo F, Cesario A, Leuzzi G and Apolone G: Second primary on-small-cell lung cancer: Implications of the new adenocarcinoma classification in the challenging decision of the best surgical strategy. Eur J Cardiothorac Surg 45: 1115-1116, 2014.
4. Farías RO, Bortolussi S, Menéndez PR and González SJ: Exploring Boron Neutron Capture Therapy for non-small cell lung cancer. Phys Med 30: 888-897, 2014.
5. Zhang Y, Ma M and Han B: GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: An immunohistochemical analysis. Tumour Biol 35: 10833-10839, 2014.
6. Zhang J, Xu L, Yang Z, Lu H, Hu D, Li W, Zhang Z, Liu B and Ma S: MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin. Clin Transl Oncol 17: 209-214, 2015.
7. Zhang L, Qian J, Qiang Y, Huang H, Wang C, Li D and Xu B: Down-regulation of miR-4500 promoted non-small cell lung cancer growth. Cell Physiol Biochem 34: 1166-1174, 2014.
8. Zeuner A, Francescangeli F, Contavalli P, Zapparelli G, Apuzzo T, Eramo A, Baiocchi M, De Angelis ML, Biffoni M, Sette G, et al: Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer. Cell Death Differ 21: 1877-1888, 2014.
9. Zhang C, Lan T, Hou J, Li J, Fang R, Yang Z, Zhang M, Liu J and Liu B: NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling. Oncotarget 5: 4392-4405, 2014.
10. Wu S, Cheng Z, Yu L, Song W and Tao Y: Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry. Zhongguo Fei Ai Za Zhi 14: 918-925, 2011 (In Chinese).
11. Wang Q, Hu DF, Rui Y, Jiang AB, Liu ZL and Huang LN: Prognosis value of HIF-1α expression in patients with non-small cell lung cancer. Gene 541: 69-74, 2014.
12. Li Y, Qiu X, Zhang S, Zhang Q and Wang E: Hypoxia induced CCR7 expression via HIF-1α and HIF-2α correlates with migration and invasion in lung cancer cells. Cancer Biol Ther 8: 322-330, 2009.
13. Lv Y, and Zhang P: Advances of HIF-1α and its role in lung cancer. Zhongguo Fei Ai Za Zhi 12: 147-151, 2009 (In Chinese).
14. Jang BC: The fruit juice of Morinda citrifolia (noni) downregulates HIF-1α protein expression through inhibition of PKB, ERK-1/2, JNK-1 and S6 in manganese-stimulated A549 human lung cancer cells. Int J Mol Med 29: 499-504, 2012.
15. Liang J, Qian Y, Xu D, Yin Q and Pan HJ: Serum tumor markers, hypoxia-inducible factor-1α HIF-1α and vascular endothelial growth factor, in patients with non- small cell lung cancer before and after intervention. Asian Pac J Cancer Prev 14: 3851-3854, 2013.
16. Wang Q, Li LH, Gao GD, Wang G, Qu L, Li JG and Wang CM: HIF-1α up-regulates NDRG1 expression through binding to NDRG1 promoter, leading to proliferation of lung cancer A549 cells. Mol Biol Rep 40: 3723-3729, 2013.
17. Li L, Hu M, Yu JM, Yang GR, Guo HB and Gao Y: Correlations of 99 Tc m-HL91 SPECT hypoxia imaging with HIF-1α and VEGF expression in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 31: 669-673, 2009 (In Chinese).
18. Choi YJ, Rho JK, Lee SJ, Jang WS, Lee SS, Kim CH and Lee JC: HIF-1α modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines. J Cancer Res Clin Oncol 135: 1047-1053, 2009.
19. Zuo S, Ji Y, Wang J and Guo J: Expression and clinical implication of HIF-1α and VEGF-C in non-small cell lung cancer. J Huazhong Univ Sci Technolog Med Sci 28: 674-676, 2008.
20. Li Y, Zhang Q, Jiang L, Qiu X, Wang E: Upregulation of the chemokine receptor CCR7 expression by HIF-1α and HIF-2α in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 11: 724-728, 2008 (In Chinese).
21. Ai B, Pan T, Zheng Z and Chen T: The relationship of expression of GLUT1, HIF-1α and the uptake of FDG in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 10: 508-512, 2007 (In Chinese).
22. Song X, Liu X, Chi W, Liu Y, Wei L, Wang X and Yu J: Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene. Cancer Chemother Pharmacol 58: 776-784, 2006.
23. Zhu C, Wang X, Zheng H, Liu T, Li Y, Sun C, Wang A, Zhao F: Expressions of EphB4 and HIF-1α in human lung cancer and their significances. Zhongguo Fei Ai Za Zhi 8: 99-102, 2005.
24. Chang H, Shyu KG, Lee CC, Tsai SC, Wang BW, Hsien Lee Y and Lin S: GL331 inhibits HIF-1α expression in a lung cancer model. Biochem Biophys Res Commun 302: 95-100, 2003.
25. Jacoby JJ, Erez B, Korshunova MV, Williams RR, Furutani K, Takahashi O, Kirkpatrick L, Lippman SM, Powis G, O'Reilly MS, et al: Treatment with HIF-1α antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. J Thorac Oncol 5: 940-949, 2010.
26. Wan J, Ma J, Mei J and Shan G: The effects of HIF-1α on gene expression profiles of NCI-H446 human small cell lung cancer cells. J Exp Clin Cancer Res 28: 150, 2009.
27. Peng Z, Shan C and Wang H: Expression of VHL and HIF-1α and its clinical significance in the lung cancer tissue. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34: 331-334, 2009 (In Chinese).
28. Naruke A, Azuma M, Takeuchi A, Ishido K, Katada C, Sasaki T, Higuchi K, Tanabe S, Saegusa M and Koizumi W: Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer. Gastric Cancer 18: 262-270, 2015.
29. Wang HL and Zhang ZL: Analysis of the relationship between ultrasound of breast cancer DOT-SDI and the expression of MVD, VEGF and HIF-1α. Cell Biochem Biophys 70: 205-208, 2014.
30. Zhou Z, Liu F, Zhang ZS, Shu F, Zheng Y, Fu L and Li LY: Human rhomboid family-1 suppresses oxygen-independent degradation of hypoxia-inducible factor-1α in breast cancer. Cancer Res 74: 2719-2730, 2014.
31. Anavi S, Hahn-Obercyger M, Madar Z and Tirosh O: Mechanism for HIF-1 activation by cholesterol under normoxia: A redox signaling pathway for liver damage. Free Radic Biol Med 71: 61-69, 2014.
32. Jo JR, Park YK and Jang BC: Short-term treatment with glucosamine hydrochloride specifically downregulates hypoxia-inducible factor-1α at the protein level in YD-8 human tongue cancer cells. Int J Oncol 44: 1699-1706, 2014.
33. Chen L, Shi Y, Yuan J, Han Y, Qin R, Wu Q, Jia B, Wei B, Wei L, Dai G, et al: HIF-1 α overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy. PLoS One 9: e90678, 2014.
34. Clara CA, Marie SK, de Almeida JR, Wakamatsu A, Oba-Shinjo SM, Uno M, Neville M and Rosemberg S: Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma. Neuropathology 34: 343-352, 2014.
35. Liu H, Liu Z, Li J Li Q, You C and Xu J: Relative quantitative expression of hypoxia-inducible factor 1α messenger ribonucleic acid in recurrent craniopharyngiomas. Neurol India 62: 53-56, 2014.
36. Green DR: Apoptotic pathways: Paper wraps stone blunts scissors. Cell 102: 1-4, 2000.
37. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387: 773-776, 1997.
38. De Luca A, Maiello MR, D'Alessio A, Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 16 (Suppl 2): S17-S27, 2012.
39. Heeg S, Hirt N, Queisser A, Schmieg H, Thaler M, Kunert H, Quante M, Goessel G, von Werder A, Harder J, et al: EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-α in a cellular model of oral-esophageal carcinogenesis. Cancer Sci 102: 351-360, 2011.
40. Richard DE, Berra E, Gothié E, Roux D and Pouysségur J: p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274: 32631-32637, 1999.
41. Minet E, Arnould T, Michel G, Roland I, Mottet D, Raes M, Remacle J and Michiels C: ERK activation upon hypoxia: Involvement in HIF-1 activation. FEBS Lett 468: 53-58, 2000.
42. Hur E, Chang KY, Lee E, Lee SK and Park H: Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1α. Mol Pharmacol 59: 1216-1224, 2001.
43. van den Tweel ER, Kavelaars A, Lombardi MS, Nijboer CH, Groenendaal F, van Bel F and Heijnen CJ: Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage. Pediatr Res 59: 434-439, 2006.
44. Zhang E, Feng X, Liu F, Zhang P, Liang J and Tang X: Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS One 9: e103440, 2014.
45. Yamagishi S, Matsui T, Nakamura K, Yoshida T, Shimizu K, Takegami Y, Shimizu T, Inoue H and Imaizumi T, et al: Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties. Microvasc Res 71: 222-226, 2006.